Proler 10 mg (Tablet)

Unit Price: ৳ 2.52 (50's pack: ৳ 126.00)

Medicine Details

Indications

  • Relief of symptoms associated with seasonal & perennial allergic rhinitis
  • Treatment of uncomplicated skin manifestations of chronic idiopathic urticaria
  • Treatment of allergen induced asthma

Pharmacology

  • Potent H1 receptor antagonist
  • No significant anticholinergic and antiserotonic effects
  • No drowsiness effect
  • Inhibition of histamine-mediated early phase of allergic reaction
  • Reduction of migration of inflammatory cells and release of mediators associated with late phase of allergic reaction
  • Peak plasma concentrations of 257 mcg/L within one hour of administration for adults
  • Peak plasma concentrations of 980 mcg/L within one hour of administration for children
  • Plasma half-life of approximately 11 hours
  • Renal clearance of 30 ml/minute
  • Excretion half-life of approximately nine hours

Dosage & Administration

  • Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily
  • Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily
  • Children 6 months to 2 years: 1/2 teaspoonful once daily
  • Recommended dosage regimen for Cetirizine injectable form for different age groups
  • Cetirizine is a single use injectable product for intravenous administration only
  • Not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function

Interaction

  • No clinically significant drug interactions with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole, or Erythromycin

Contraindications

  • Hypersensitivity to Cetirizine or hydroxyzine

Side Effects

  • Most common side effect is somnolence

Pregnancy & Lactation

  • US FDA Pregnancy Category B
  • No adequate and well-controlled studies in pregnant women
  • Caution should be exercised when administered to a nursing woman

Precautions & Warnings

  • Caution should be exercised when driving a car or operating heavy machinery

Use in Special Populations

  • Total body clearance of Proler is reduced and AUC and half-life increased in patients with mild to moderate hepatic and renal impairment
  • Plasma levels are unaffected by hemodialysis
  • Safety demonstrated in pediatric patients aged 6 months to 5 years
  • Clearance of Proler is reduced in elderly patients in proportion to decrease in creatinine clearance

Therapeutic Class

  • Sedating Anti-histamine

Storage Conditions

  • Keep in a dry place away from light and heat
  • Keep out of the reach of children

Related Brands